Milestone Pharmaceuticals (MIST) Net Cash Flow Growth (3y) (2021 - 2026)
Milestone Pharmaceuticals (MIST) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Milestone Pharmaceuticals | 148.53 Mn | -35.69 Mn | - | -26.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.54% |
| Dec 31, 2025 | 42.42% |
| Sep 30, 2025 | 29.29% |
| Jun 30, 2025 | 55.33% |
| Mar 31, 2025 | 42.65% |
| Dec 31, 2024 | 66.43% |
| Sep 30, 2024 | -26.70% |
| Jun 30, 2024 | -50.58% |
| Mar 31, 2024 | -100.39% |
| Dec 31, 2023 | -46.54% |
| Sep 30, 2023 | -51.62% |
| Jun 30, 2023 | -36.15% |
| Mar 31, 2023 | 78.46% |
| Dec 31, 2022 | -61.68% |
| Sep 30, 2022 | -81.74% |
| Jun 30, 2022 | -33.68% |
| Mar 31, 2022 | -14.19% |
| Dec 31, 2021 | -67.86% |
| Sep 30, 2021 | 44.25% |
| Jun 30, 2021 | 77.72% |